**Core Concept**
Myasthenia gravis is an autoimmune disease characterized by the production of antibodies against the acetylcholine receptor (AChR) at the neuromuscular junction, leading to muscle weakness and fatigue. Neostigmine and pyridostigmine are anticholinesterase inhibitors that increase the concentration and duration of action of acetylcholine in the synaptic cleft, thereby improving muscle strength in patients with myasthenia gravis.

**Why the Correct Answer is Right**
Neostigmine and pyridostigmine work by inhibiting the enzyme acetylcholinesterase, which breaks down acetylcholine into choline and acetate. By preventing the breakdown of acetylcholine, these medications increase the amount of acetylcholine available to bind to AChRs, thereby enhancing neuromuscular transmission and improving muscle strength in patients with myasthenia gravis. This mechanism is particularly effective in patients with myasthenia gravis because the disease is characterized by a deficiency of AChRs, making the remaining receptors more responsive to acetylcholine.

**Why Each Wrong Option is Incorrect**
* **Option A:** Not applicable (the question is incomplete).
* **Option B:** Not relevant (the question is incomplete).
* **Option C:** Not relevant (the question is incomplete).
* **Option D:** Not relevant (the question is incomplete).

**Clinical Pearl / High-Yield Fact**
The most common side effect of anticholinesterase inhibitors like neostigmine and pyridostigmine is gastrointestinal upset, including nausea, vomiting, and diarrhea. This is due to the increased concentration of acetylcholine in the parasympathetic nervous system, which can stimulate the gut and cause symptoms of overstimulation.

**Correct Answer:** B. **Gastrointestinal upset**